Head and Neck Neoplasms
Information
- Disease name
- Head and Neck Neoplasms
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05218824 | Active, not recruiting | Collection of Head Images During Radiotherapy | February 14, 2022 | December 31, 2024 | |
| NCT02918955 | Active, not recruiting | Phase 3 | Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection | October 2016 | May 2025 |
| NCT02568267 | Active, not recruiting | Phase 2 | Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) | November 19, 2015 | April 1, 2025 |
| NCT03765918 | Active, not recruiting | Phase 3 | Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689) | December 17, 2018 | September 10, 2026 |
| NCT06110195 | Active, not recruiting | Phase 1 | Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer | January 24, 2024 | October 2027 |
| NCT03082534 | Active, not recruiting | Phase 2 | Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma | March 28, 2017 | May 2024 |
| NCT02281955 | Active, not recruiting | Phase 2 | De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study | August 2014 | November 2024 |
| NCT04222972 | Active, not recruiting | Phase 3 | A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) | July 24, 2020 | June 30, 2025 |
| NCT03691714 | Active, not recruiting | Phase 2 | Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | October 23, 2018 | December 2024 |
| NCT03818061 | Active, not recruiting | Phase 2 | Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck | March 26, 2019 | March 1, 2024 |
| NCT02229656 | Active, not recruiting | Phase 1 | Olaparib and Radiotherapy in Head and Neck Cancer | September 24, 2014 | January 2024 |
| NCT03040999 | Active, not recruiting | Phase 3 | Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412) | April 5, 2017 | August 16, 2024 |
| NCT01856478 | Active, not recruiting | Phase 3 | LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy | May 23, 2013 | August 31, 2024 |
| NCT03401840 | Active, not recruiting | N/A | STEREO-POSTOP 01 (PostOperative Hypofractionated Stereotactic Body Radiotherapy ) - GORTEC 2017-03 | January 23, 2018 | January 2024 |
| NCT05511714 | Available | Expanded Access [11C] Methionine PET Imaging | |||
| NCT00239304 | Completed | Phase 1/Phase 2 | Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer | June 2003 | March 2006 |
| NCT00243347 | Completed | Phase 1 | The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer | December 2005 | July 2009 |
| NCT00248235 | Completed | Phase 2/Phase 3 | Resistance Exercise Training for the Shoulder and Neck Following Surgery for Head and Neck Cancer | September 2005 | January 2009 |
| NCT00252473 | Completed | Phase 2 | S-Frame CT Immobilization Masks For Patients Undergoing Radiation Therapy For Head and Neck Cancer | January 2005 | June 2009 |
| NCT00261703 | Completed | Phase 2/Phase 3 | Docetaxel in Head and Neck Cancer | December 2002 | July 2010 |
| NCT00268671 | Completed | Phase 1/Phase 2 | Docetaxel in Squamous Cell Carcinoma of the Head and Neck (TAX + Cisplatin in SCCHN) | August 2003 | April 2006 |
| NCT00328458 | Completed | Phase 1 | EPO906 Plus Radiation Therapy for the Treatment of Cancer Patients | February 2004 | July 2009 |
| NCT00357149 | Completed | Phase 2 | Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Patients (SCCHNS) | January 2003 | |
| NCT00358930 | Completed | Phase 2 | A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck | July 2006 | August 2007 |
| NCT00375414 | Completed | N/A | Role of Prophylactic Antibiotics in New Introducer PEG-Gastropexy | October 2003 | April 2007 |
| NCT00400426 | Completed | Phase 2 | DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer | November 2006 | June 2012 |
| NCT00401323 | Completed | Phase 2/Phase 3 | Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | January 1998 | June 2003 |
| NCT00402545 | Completed | Phase 1 | C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck | January 2007 | July 2009 |
| NCT00415194 | Completed | Phase 3 | A Study for Patients With Head and Neck Cancer | December 2006 | March 2010 |
| NCT00496236 | Completed | Phase 1/Phase 2 | Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer | ||
| NCT00496535 | Completed | Phase 1/Phase 2 | A Study of TNFerade™ Biologic With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) in Patients With Head and Neck Cancer | ||
| NCT00514943 | Completed | Phase 2 | BIBW 2992 (Afatinib) in Head & Neck Cancer | August 2007 | July 2013 |
| NCT00519077 | Completed | Phase 2 | Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck | March 2005 | May 2013 |
| NCT00521521 | Completed | Phase 2 | Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Neck Cancer | July 2001 | |
| NCT00721799 | Completed | Phase 2 | F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients | March 1, 2008 | December 31, 2014 |
| NCT00768664 | Completed | Phase 2 | Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Neck Squamous Cell Cancer | November 4, 2008 | April 18, 2012 |
| NCT00772681 | Completed | Phase 4 | Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx Carcinoma | October 2004 | March 2008 |
| NCT00841191 | Completed | Phase 1/Phase 2 | A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors | March 2009 | April 2011 |
| NCT00916097 | Completed | Phase 2 | NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT) | July 2002 | November 2005 |
| NCT00923481 | Completed | Phase 2 | A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H... | April 2009 | January 2012 |
| NCT00978250 | Completed | Phase 2 | A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU) | August 20, 2009 | April 11, 2019 |
| NCT00993512 | Completed | Phase 1 | Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Cancer | August 2009 | May 2011 |
| NCT00995293 | Completed | Phase 3 | Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial | August 27, 2009 | January 26, 2018 |
| NCT01195922 | Completed | Phase 1/Phase 2 | Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma | August 2010 | December 2015 |
| NCT00050388 | Completed | Phase 3 | Phase II Trial of Allovectin-7® for Head and Neck Cancer | June 2002 | |
| NCT00057512 | Completed | Phase 1 | Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck | January 2003 | December 2003 |
| NCT00093041 | Completed | Phase 1/Phase 2 | Zalutumumab in Head and Neck Cancer | December 1, 2003 | January 12, 2005 |
| NCT00094081 | Completed | Phase 3 | Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer | October 2002 | September 2006 |
| NCT00100204 | Completed | Salivary Proteins in Disease and Health | December 21, 2004 | April 19, 2011 | |
| NCT00123097 | Completed | Phase 3 | Clinical Trial of New Elastomer for Maxillofacial Prosthetics | February 2005 | August 2009 |
| NCT00135161 | Completed | Phase 1 | Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer | September 2003 | August 2015 |
| NCT00138827 | Completed | Phase 4 | Mouth Care Regimes During Radiotherapy | November 1999 | March 2003 |
| NCT00144976 | Completed | N/A | Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma | October 2003 | December 2006 |
| NCT00147862 | Completed | Phase 3 | Does Tranexamic Acid Administration Reduce Blood Loss During Head and Neck Surgery? | May 2005 | January 2007 |
| NCT00163176 | Completed | Value of FLT-PET Before and During Radiotherapy in Head and Neck Tumors | July 2005 | December 2010 | |
| NCT00180180 | Completed | Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO | July 2006 | October 2018 | |
| NCT00184860 | Completed | N/A | The Role of CT-PET-MRI Image Fusion in Determining Radiation Treatment Volumes of Head-and-Neck Cancer Patients | June 2003 | |
| NCT00199160 | Completed | Phase 2 | Efficacy and Activity of BAY 43-9006 in Patients With Recurrent and/or Metastatic Head and Neck Cancer | April 2005 | June 2010 |
| NCT01025518 | Completed | N/A | DAHANCA 25A: Resistance Training and Dietary Supplements as Intervention for Regaining Muscle Mass Following Radiotherapy in Head and Neck Cancer Patients | September 2009 | January 2012 |
| NCT01057589 | Completed | Phase 2 | A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer | February 2010 | October 2012 |
| NCT01059357 | Completed | N/A | Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Lesions Using Da Vinci Robotic Surgical System | June 2010 | October 2014 |
| NCT01065844 | Completed | Phase 2 | Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck | October 2009 | November 2017 |
| NCT01087970 | Completed | Phase 2 | A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer | August 2010 | August 2013 |
| NCT01187173 | Completed | The Fibrosis-Lymphedema Continuum in Head and Neck Cancer | July 2010 | November 2014 | |
| NCT01235052 | Completed | N/A | Prognostic Evaluation of 18fmiso Pet-ct in Head and Neck Cancer | June 2009 | July 2014 |
| NCT01283334 | Completed | Phase 1/Phase 2 | A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer | January 2011 | November 2014 |
| NCT01345682 | Completed | Phase 3 | LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy | January 5, 2012 | December 6, 2016 |
| NCT01530997 | Completed | Phase 2 | De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca | February 7, 2012 | November 2019 |
| NCT01566435 | Completed | Phase 2 | Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer | August 9, 2012 | October 31, 2019 |
| NCT01639911 | Completed | Phase 1 | Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors | August 14, 2013 | July 28, 2016 |
| NCT01737450 | Completed | Phase 2 | Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive | January 2013 | March 2019 |
| NCT02017288 | Completed | Study to Evaluate the Natural History of Head and Neck Cancer Precursors in Taiwan | November 18, 2013 | February 4, 2021 | |
| NCT02085941 | Completed | N/A | Image-guided Cryoablation of Head, Neck and Spine Tumors | February 2015 | July 2021 |
| NCT02107235 | Completed | Phase 1 | Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer | January 2014 | January 2015 |
| NCT02188563 | Completed | N/A | A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers | May 2014 | May 2016 |
| NCT02204033 | Completed | Phase 1 | Dose Escalation Study With 99mTC - or 186 Re-labelled Humanised Monoclonal Antibody (hMAb) BIWA 4 in Patients With Head and Neck Cancer | March 1999 | |
| NCT02251730 | Completed | Phase 2 | Smoking Cessation in Head and Neck Cancer Patients Receiving Curative Radiation Therapy | August 2014 | May 2016 |
| NCT02254018 | Completed | Phase 1 | Single Dose Escalation Study of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck | September 1, 2002 | |
| NCT02284802 | Completed | N/A | Early Detection of Tumors of the Digestive Tract by Confocal Endomicroscopy | September 10, 2014 | March 10, 2023 |
| NCT02324335 | Completed | Phase 2 | Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer | August 14, 2014 | November 22, 2017 |
| NCT02332161 | Completed | Leg Function and ADL After ALT Reconstruction for Head and Neck Cancer | January 2014 | June 26, 2017 | |
| NCT02335112 | Completed | N/A | Irreversible Electroporation(IRE) For Unresectable Head and Neck Neoplasms | January 1, 2015 | January 1, 2021 |
| NCT02397486 | Completed | Phase 2 | The Impact of Pentoxifylline and Vitamin E on Radiotherapy-induced Toxicity in Head & Neck Cancer Patients | May 2, 2015 | June 30, 2018 |
| NCT02439892 | Completed | N/A | Rehabilitation for Head and Neck Cancer | April 2015 | April 1, 2017 |
| NCT02442375 | Completed | Phase 3 | Uniform FDG-PET Guided Gradient Dose Prescription to Reduce Late Radiation Toxicity | June 2016 | March 8, 2024 |
| NCT02460471 | Completed | Phase 2 | Palliative Radiotherapy Protocol in Head and Neck Cancer | June 2011 | April 2015 |
| NCT02478138 | Completed | N/A | Sentinel Lymph Node Mapping of Oral Cancer Using Near-Infrared Fluorescence Imaging | May 2015 | January 8, 2024 |
| NCT02545322 | Completed | N/A | Image Guided Adaptive Radiotherapy in the Head-and-neck Region | February 2012 | August 2013 |
| NCT02548377 | Completed | N/A | Remote Ischemic Preconditioning in Head and Neck Cancer Reconstruction - A Randomized Controlled Trial | September 29, 2015 | February 26, 2018 |
| NCT02555644 | Completed | Phase 1 | A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck Cancer | February 24, 2016 | January 14, 2019 |
| NCT02597582 | Completed | Phase 4 | LigaSure Small Jaw® Versus Conventional Neck Dissection in Head and Neck Cancer Patients | January 2014 | October 2015 |
| NCT02622880 | Completed | Phase 4 | Comparison of Two Immunomodulatory Formulas on the Number of Postoperative Infections in Head & Neck Cancer Patients | February 2013 | June 2014 |
| NCT02643550 | Completed | Phase 1/Phase 2 | Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | December 2015 | March 28, 2023 |
| NCT02647021 | Completed | N/A | Therapeutic Resistance Group Exercise Training for Head & Neck Cancer Survivors | March 31, 2016 | March 30, 2020 |
| NCT02836769 | Completed | N/A | Development and Evaluation of Rehabilitation Consult for Survivors of Head and Neck Cancer | January 2016 | May 2018 |
| NCT02857413 | Completed | Frequency of Xerostomia and Their Management in Upper Aerodigestive Tract Cancer Patients After the End of Radiotherapy | January 2016 | July 2016 | |
| NCT02941276 | Completed | N/A | A Trial Looking at Treating Dry Mouth After Radiotherapy for Head and Neck Cancer | November 2011 | November 2014 |
| NCT02946021 | Completed | Phase 1/Phase 2 | Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema | October 2016 | February 2018 |
| NCT02966509 | Completed | N/A | Engagement of Patients With Advanced Cancer | August 2013 | December 2016 |
| NCT03003637 | Completed | Phase 1/Phase 2 | ImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced or Recurrent Head and Neck Carcinoma | February 28, 2017 | February 12, 2021 |
| NCT03034603 | Completed | N/A | The Safety and Efficacy Test of Nutri-PEITC Jelly in Head and Neck Cancer Patients | August 2014 | January 2023 |
| NCT03037385 | Completed | Phase 1/Phase 2 | Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors | March 17, 2017 | March 21, 2024 |
| NCT03047174 | Completed | N/A | Radiotherapy Related Skin Toxicity: Mepitel® vs. Standard Care in Patients With Locally Advanced Head-and-Neck Cancer | May 9, 2017 | July 16, 2019 |
| NCT03077243 | Completed | Phase 2 | P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC | December 2016 | December 14, 2022 |
| NCT03092934 | Completed | Phase 1/Phase 2 | A Study of AK-01 (LY3295668) in Solid Tumors | May 29, 2017 | April 20, 2020 |
| NCT03225157 | Completed | Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation | November 3, 2017 | February 28, 2020 | |
| NCT03252509 | Completed | N/A | Outpatient Percutaneous Radiologic Gastrostomy in Patients With Head and Neck Tumors | March 20, 2017 | November 21, 2018 |
| NCT03292250 | Completed | Phase 2 | Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)] | September 10, 2017 | March 10, 2022 |
| NCT03332160 | Completed | N/A | A Pilot Study to Evaluate the Feasibility and Potential Effectiveness of the Flexitouch System Head and Neck Treatment | January 2, 2018 | July 31, 2019 |
| NCT03345719 | Completed | The Translational Research Image-Guided Operating Room (TRIGORA): Intraoperative 3D Imaging for Head & Neck Surgical Patients | October 4, 2012 | March 31, 2019 | |
| NCT03443258 | Completed | N/A | Needs Assessment Tool Integrated in Clinical Practice of Head and Neck Cancer Rehabilitation | June 11, 2018 | November 30, 2019 |
| NCT03546322 | Completed | Customized Registry Tool for Tracking Adherence to Clinical Guidelines for Head and Neck Cancers | June 1, 2018 | March 30, 2022 | |
| NCT03547388 | Completed | Phase 1 | Moderate Whole Body Hyperthermia for Patients Undergoing Re-irradiation for Head and Neck Cancer -Influence on the Tumor Microenvironment | July 1, 2018 | May 4, 2020 |
| NCT03549494 | Completed | Phase 2 | Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction | October 25, 2018 | February 15, 2023 |
| NCT03672799 | Completed | N/A | Rehabilitation Planning Consult Phase II Trial | January 7, 2019 | July 7, 2021 |
| NCT03695510 | Completed | Phase 2 | Afatinib and Pembrolizumab for Head and Neck Squamous Cell Carcinoma (ALPHA Study) | January 24, 2019 | April 14, 2022 |
| NCT03753932 | Completed | N/A | Impact of Fixed Dentures in Head and Neck Cancer (IMFDHAC) | March 1, 2013 | September 17, 2021 |
| NCT04208334 | Completed | Phase 2 | The Effect of Curcumin for Treatment of Cancer Anorexia-Cachexia Syndrome in Patients With Stage III-IV of Head and Neck Cancer | February 13, 2020 | March 31, 2021 |
| NCT04247282 | Completed | Phase 1/Phase 2 | Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection | June 9, 2020 | June 12, 2023 |
| NCT04260074 | Completed | Epigenetic Changes in Head and Neck Cancer | March 11, 2020 | July 14, 2021 | |
| NCT04266015 | Completed | N/A | Anabolic Effects of Intraoperative Feeding in Reconstruction Surgery | April 16, 2020 | April 13, 2022 |
| NCT04420689 | Completed | Phase 1/Phase 2 | A Study of ALM-488 to Highlight Nerves in Patients Undergoing Head & Neck Surgery | June 18, 2020 | February 15, 2022 |
| NCT04525066 | Completed | Phase 2 | Phonosurgical Augmentation After Laser Resection of Early Glottic Carcinoma | August 13, 2013 | August 13, 2018 |
| NCT04758026 | Completed | H&N Cancer; Survivorship and Late Effects | October 10, 2018 | October 10, 2020 | |
| NCT04782726 | Completed | N/A | Radiation Therapy Plan Quality Improvement Using Ideal Theoretical Isodose Distribution | December 16, 2021 | January 20, 2023 |
| NCT04866498 | Completed | Pharmacotherapy Personalization of Cancer Patients | July 1, 2016 | March 31, 2021 | |
| NCT05068687 | Completed | N/A | Peroperative Assessment of Malignancies of the Head and Neck Using High-resolution 18F-FDG-PET/CT | August 28, 2020 | September 30, 2022 |
| NCT05227807 | Completed | N/A | The Efficacy of Mouth Exercise in Oral Cancer Patients After Receiving Surgery | July 7, 2012 | December 12, 2014 |
| NCT05269342 | Completed | N/A | Nurse-led Exercise Improves Shoulder Pain, Shoulder Disability, and Quality of Life in Head and Neck Cancer | September 14, 2017 | September 9, 2018 |
| NCT05614843 | Completed | N/A | Photobiomodulation Therapy in Patients With Head and Neck Cancer Post-Radiotherapy | October 1, 2022 | July 31, 2023 |
| NCT05962944 | Completed | Remote Rapid Onsite Evaluation (ROSE) for Head and Neck Fine Needle Aspirations (FNA) | October 25, 2022 | July 24, 2023 | |
| NCT06446570 | Completed | Phase 2 | Phase II Study of Durvalumab(MEDI4736) + Tremelimumab in Pulmonary Sarcomatoid Carcinoma | September 10, 2017 | June 3, 2021 |
| NCT06458517 | Not yet recruiting | N/A | Evaluation of Two Methods of Administration of Photobiomodulation in the Context of the Prevention and Treatment of Mucositis Induced by Radiotherapy, During the Treatment of Head and Neck Cancers | September 2, 2024 | May 2, 2026 |
| NCT03051906 | Not yet recruiting | Phase 1/Phase 2 | Durvalumab, Cetuximab and Radiotherapy in Head Neck Cancer | January 2018 | January 2025 |
| NCT05341206 | Not yet recruiting | Phase 2 | Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a Pilot Study. | April 15, 2022 | December 31, 2025 |
| NCT06289049 | Not yet recruiting | Phase 2 | Heavy Strength Training in Head and Neck Cancer Survivors | September 2024 | April 2026 |
| NCT06398899 | Not yet recruiting | N/A | Sugammadex v.s. Neostigmine/Glycopyrrolate | May 1, 2024 | January 31, 2025 |
| NCT06347185 | Not yet recruiting | N/A | Simultaneous Care in Recurrent and/or Metastatic Head and Neck Cancer: the SupCare Study | September 2024 | December 2028 |
| NCT05664906 | Not yet recruiting | Phase 1/Phase 2 | Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer Patients | January 31, 2023 | November 30, 2024 |
| NCT06215612 | Not yet recruiting | N/A | ctDNA and MRI Parameters in Head and Neck Cancer | February 2024 | February 2030 |
| NCT04405154 | Not yet recruiting | Phase 2 | A Study of Concomitant Camrelizumab With Chemoradiation for Locally Advanced Head and Neck Cancer | June 1, 2020 | May 31, 2025 |
| NCT03975465 | Recruiting | N/A | EMST and Swallowing in Long-Term Survivors of HNCA | September 10, 2018 | October 1, 2025 |
| NCT03981068 | Recruiting | N/A | DAHANCA 37. Re-irradiation With Proton Radiotherapy | September 1, 2019 | August 30, 2025 |
| NCT04075305 | Recruiting | The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study | February 1, 2019 | May 1, 2025 | |
| NCT04028479 | Recruiting | The Registry of Oncology Outcomes Associated With Testing and Treatment | May 5, 2021 | October 1, 2031 | |
| NCT05187091 | Recruiting | Phase 3 | The SWOAR Trial Sparing of Swallowing and Aspiration Related Organs at Risk & Submandibular Gland With Intensity Modulated Radiotherapy Versus Standard IMRT in Head and Neck Squamous Cell Carcinomas | July 11, 2021 | June 2025 |
| NCT06335342 | Recruiting | Radiotherapy Treatments for Neoplasms in the Head and Neck Region | February 22, 2018 | December 31, 2024 | |
| NCT05412849 | Recruiting | Radiation Field, Dose and Fractionation Related to Mandibular Complications | January 1, 2023 | July 2025 | |
| NCT05418842 | Recruiting | N/A | Exercise Prehabilitation in Patients With Head and Neck Squamous-cell Carcinoma: The FIT4TREAT Trial | June 1, 2021 | December 31, 2024 |
| NCT05106608 | Recruiting | N/A | Photobiomodulation Therapy Plus M-health in Head and Neck Cancer Patients: LAXER Study | July 13, 2022 | July 2025 |
| NCT05420948 | Recruiting | Phase 2 | A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer | October 17, 2022 | December 1, 2026 |
| NCT02395367 | Recruiting | Prospective, Observational, Real-world Oral Malignant Tumors Study | March 2015 | March 2025 | |
| NCT04612075 | Recruiting | The EMINENCE Study - PET/MR Imaging of Head Neck Cancer | January 12, 2021 | December 2028 | |
| NCT05432297 | Recruiting | N/A | Preventive Physical Activity Intervention in Head and Neck Cancer | January 2, 2023 | December 2031 |
| NCT05483400 | Recruiting | Phase 2 | Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors | October 18, 2023 | September 2027 |
| NCT05260671 | Recruiting | Phase 2 | Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN | January 25, 2022 | December 25, 2026 |
| NCT05022667 | Recruiting | N/A | Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy | December 1, 2021 | August 2024 |
| NCT06365866 | Recruiting | N/A | Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer. | February 19, 2024 | December 2024 |
| NCT05544136 | Recruiting | Phase 2 | A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer | September 12, 2022 | March 12, 2027 |
| NCT03343236 | Recruiting | Nutrition and Inflammation in Patients With Head and Neck Cancer | November 1, 2015 | December 31, 2027 | |
| NCT04598087 | Recruiting | N/A | Prehabilitation and Recovery After Head and Neck Cancer Surgery | February 9, 2022 | December 31, 2024 |
| NCT06237881 | Recruiting | Phase 1/Phase 2 | A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors | January 31, 2024 | January 1, 2029 |
| NCT03429036 | Recruiting | Biospecimen Procurement for Head and Neck Disorders | May 23, 2018 | December 3, 2026 | |
| NCT05647122 | Recruiting | Phase 1 | First in Human Study of AZD9592 in Solid Tumors | December 22, 2022 | October 29, 2025 |
| NCT02557048 | Recruiting | Head and Neck Cancer in Children: A Retrospective Study | January 10, 2019 | December 2023 | |
| NCT05308732 | Recruiting | Phase 1 | Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy | May 11, 2021 | April 2024 |
| NCT05763615 | Recruiting | N/A | 3D Modeling of the Cervico-facial Region and Cranial Nerve Tractography: IMAG 2 ORL Project | May 10, 2023 | May 2025 |
| NCT05785247 | Recruiting | ENHANCE - Evaluating the Implementation of Head and Neck Cancer E-health | June 14, 2023 | March 31, 2025 | |
| NCT04429542 | Recruiting | Phase 1 | Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors | June 1, 2020 | June 1, 2025 |
| NCT06303180 | Recruiting | NIDCD Otolaryngology Clinical Protocol Biospecimen Bank | March 4, 2024 | December 30, 2033 | |
| NCT05811936 | Recruiting | N/A | The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads | August 23, 2023 | May 31, 2026 |
| NCT06216171 | Recruiting | N/A | Adaptive Radiotherapy in Head and Neck Tumor Patients | January 25, 2024 | January 30, 2028 |
| NCT05944237 | Recruiting | Phase 1/Phase 2 | HTL0039732 in Participants With Advanced Solid Tumours | July 13, 2023 | September 2026 |
| NCT05954676 | Recruiting | N/A | Online Peri-operative Education Program for Patients Undergoing Major Head & Neck Surgery | July 17, 2023 | October 31, 2024 |
| NCT03622164 | Recruiting | N/A | Unilateral Neck Radiotherapy in Head and Neck Cancer | December 21, 2018 | September 2028 |
| NCT05980598 | Recruiting | Phase 2 | TransCon (TC) TLR7/8 Agonist, TC IL-2 β/γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma | September 29, 2023 | July 30, 2027 |
| NCT06291610 | Recruiting | N/A | Feasibility Testing a Decision-support Intervention for Clinical Trials | February 19, 2024 | December 31, 2026 |
| NCT00200486 | Recruiting | Molecular and Genomic Profiling of Head and Neck Tumors | May 2002 | December 2025 | |
| NCT03914378 | Recruiting | The Effects on Auditory Function of RADiotherapy and Chemotherapy Treatments for Head and Neck Tumours (EARAD) | May 1, 2019 | December 2026 | |
| NCT04188951 | Recruiting | Early Phase 1 | HFHS-1801-A Pilot Study of Immunotherapy as Consolidation Therapy for Patients With Recurrent Head and Neck Cancer | October 4, 2019 | December 30, 2023 |
| NCT03916809 | Recruiting | N/A | EMST in Patients Undergoing CRT for HNCA | July 12, 2017 | August 1, 2024 |
| NCT03942380 | Recruiting | N/A | Cell-free Tumor DNA in Head and Neck Cancer Patients | February 1, 2017 | February 1, 2025 |
| NCT04124198 | Recruiting | N/A | Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma | March 1, 2019 | January 2029 |
| NCT02817113 | Terminated | Phase 1 | Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer | June 2016 | September 2018 |
| NCT02900248 | Terminated | CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice | October 2, 2017 | March 29, 2019 | |
| NCT00557206 | Terminated | Phase 2 | Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer | April 2005 | November 2009 |
| NCT02975739 | Terminated | N/A | Feasibility of Holmium-166 Micro Brachytherapy in Head and Neck Tumors | September 2016 | September 5, 2018 |
| NCT03020823 | Terminated | Phase 2 | To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer | April 30, 2017 | November 20, 2018 |
| NCT00506324 | Terminated | Oropharyngeal Function After Radiotherapy With IMRT | June 2006 | June 2014 | |
| NCT00412776 | Terminated | Phase 2/Phase 3 | Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer | December 2005 | April 2008 |
| NCT03286972 | Terminated | PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning | September 12, 2017 | June 20, 2019 | |
| NCT00073450 | Terminated | Phase 2 | Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530) | September 2003 | June 2004 |
| NCT03321903 | Terminated | EPR Tumor Oximetry With CE India Ink | August 30, 2017 | October 27, 2019 | |
| NCT03515824 | Terminated | Phase 1 | Study of MK-1697 in Participants With Advanced Solid Tumors (MK-1697-001) | August 13, 2018 | February 18, 2020 |
| NCT03540953 | Terminated | N/A | Endoscopic Injection of Mitomycin C for the Treatment of Pharyngoesophageal Stenosis | January 5, 2015 | January 5, 2018 |
| NCT00358007 | Terminated | Phase 2 | Use of Cone Beam Kilovoltage Imaging in Patients Receiving Radiation Therapy for Head and Neck Cancer | March 2007 | September 2010 |
| NCT03780725 | Terminated | Phase 1 | This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091 | January 22, 2019 | December 8, 2020 |
| NCT00272181 | Terminated | Phase 2 | Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer | January 2006 | October 2007 |
| NCT00011492 | Terminated | Patient Evaluation for Head and Neck Surgery Branch Studies | March 12, 2001 | November 23, 2020 | |
| NCT01216020 | Terminated | Phase 2 | Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer | October 2010 | May 20, 2015 |
| NCT01333852 | Terminated | Phase 2 | Metformin Plus Paclitaxel for Metastatic or Recurrent Head and Neck Cancer | February 2011 | April 2014 |
| NCT01345669 | Terminated | Phase 3 | LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy | October 17, 2011 | September 12, 2016 |
| NCT01479348 | Terminated | Early Phase 1 | Imaging Study for FdCyd and THU Cancer Treatment | November 1, 2011 | January 11, 2019 |
| NCT01975766 | Terminated | N/A | Ketogenic Diet Phase 1 for Head & Neck Cancer | January 2014 | July 11, 2017 |
| NCT02015650 | Terminated | Phase 4 | Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck | April 2014 | April 19, 2016 |
| NCT02045186 | Terminated | N/A | Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC) | December 2013 | November 2014 |
| NCT02131155 | Terminated | Phase 3 | LUX-Head & Neck 4: Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy | July 17, 2014 | August 22, 2016 |
| NCT02183246 | Terminated | Phase 3 | Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients | May 2000 | |
| NCT02209701 | Terminated | Phase 1 | Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors | December 1999 | |
| NCT00937612 | Terminated | N/A | Postoperative Concurrent Chemoradiation for Head and Neck Cancer With Multiple Minor Risk | June 2008 | March 2014 |
| NCT04634825 | Terminated | Phase 2 | Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck Cancer | March 17, 2021 | July 29, 2022 |
| NCT02421458 | Terminated | N/A | Comparing Two Palliative Schemes of Radiotherapy for Head and Neck Cancer | November 2015 | November 2018 |
| NCT04644315 | Terminated | Phase 2 | A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors | May 24, 2021 | May 16, 2022 |
| NCT02485470 | Terminated | Phase 2 | Benefits of MPACT in Locally Advanced Head and Neck Cancer Patients Undergoing Chemoradiotherapy | February 2016 | October 2018 |
| NCT04996147 | Terminated | Acute and Long-term Impact of Cancer Treatment on Head and Neck Cancer Patients: FIT4TREATMENT | June 1, 2019 | March 3, 2020 | |
| NCT02557529 | Terminated | N/A | Progressive Resistance Training in Head and Neck Cancer Patients During Concomitant Chemoradiotherapy | August 2015 | January 2020 |
| NCT02629029 | Terminated | N/A | Multi-Modality Imaging for Head & Neck Cancer Free Flap Design Assessment | May 30, 2015 | November 27, 2020 |
| NCT02633800 | Terminated | Phase 2 | Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN ) | December 22, 2015 | February 21, 2018 |
| NCT00159978 | Terminated | Validation of 18F-MISO-PET and 18F-FLT-PET | July 2005 | December 2013 | |
| NCT01447134 | Unknown status | RGD-K5 in Head and Neck Cancer Patients | June 2011 | June 2014 | |
| NCT02854735 | Unknown status | Total Body Composition in Detection of Nutrition Depletion in Head and Neck Patients | February 2015 | January 2018 | |
| NCT00627562 | Unknown status | N/A | A Pilot Study of the Use of the DaVinci Robotic System for Otorhinolaryngology-Head and Neck Surgery | July 2007 | December 2017 |
| NCT02943252 | Unknown status | Phase 2 | The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer | October 2016 | October 2021 |
| NCT04013178 | Unknown status | N/A | Exercise After Radiation for Head & Neck Cancer | March 31, 2017 | June 26, 2020 |
| NCT01260480 | Unknown status | Phase 2 | An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation | December 2010 | |
| NCT03989830 | Unknown status | Phase 2 | Second-Line Chemotherapy Combined With Endostatin for Recurrent/Metastatic HN Epithelial Tumors | July 29, 2019 | June 30, 2022 |
| NCT01301248 | Unknown status | Phase 2 | Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck | March 2008 | June 2011 |
| NCT04697446 | Unknown status | External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC | December 1, 2020 | October 31, 2021 | |
| NCT01985438 | Unknown status | N/A | A Trial Comparing Two Modalities of Prophylactic Nutritional Support During Treatment for Head and Neck Cancer | November 2013 | June 2015 |
| NCT05396183 | Unknown status | Accuracy and Safety of Coplanar Template Assistance for Head and Neck Biopsies. | May 25, 2022 | March 25, 2024 | |
| NCT01488669 | Unknown status | N/A | Robot Assisted Supraomohyoid Neck Dissection Via Retroauricular Approach | January 2011 | September 2013 |
| NCT04117139 | Unknown status | N/A | The Diagnostic Value of PET/MRI in Head and Neck Cancer | October 1, 2019 | September 30, 2022 |
| NCT00982436 | Unknown status | Phase 1/Phase 2 | Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer | September 2009 | December 2012 |
| NCT05318872 | Unknown status | Prospective Evaluation of ENDOSWIR Device Versus Pathology for Squamous Cell Carcinoma of Upper Aerodigestive Tract (ENDOSWIR-VADS) | April 11, 2022 | June 30, 2023 | |
| NCT02989259 | Unknown status | Phase 2 | Apatinib for Advanced Non-squamous Head and Neck Cancer | December 2016 | December 2021 |
| NCT02047487 | Unknown status | After Induction Chemotherapy of DP Plus DDP Concurrent Radiotherapy With and Without Bevacizumab Study | May 2013 | August 2018 | |
| NCT03799744 | Unknown status | Phase 1 | Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell Carcinoma | March 20, 2019 | January 31, 2023 |
| NCT04878692 | Unknown status | N/A | Evaluation of a Cosmetic Product to Preserve Skin Conditions When Using Anti-EGFR Cancer Therapies | June 1, 2021 | July 1, 2022 |
| NCT02630264 | Unknown status | Phase 3 | E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck | June 2013 | December 2016 |
| NCT03786172 | Unknown status | N/A | Efficacy of Smoking Cessation Intervention for Head and Neck Cancer Patients | January 2015 | December 2019 |
| NCT00308880 | Unknown status | Phase 3 | Tranexamic Acid and Head and Neck Surgery Patients | March 2006 | March 2007 |
| NCT02960724 | Unknown status | Phase 2 | uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer | November 2016 | August 2018 |
| NCT02837679 | Unknown status | N/A | Oncogeriatric Intervention and Follow-up at Home | January 2016 | January 2023 |
| NCT02241876 | Unknown status | Phase 4 | THE USE OF N-ACETYLCYSTEINE ATTENUATING CISPLATIN-INDUCED TOXICITIES BY OXIDATIVE STRESS | October 2014 | |
| NCT03678649 | Unknown status | Phase 2 | A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC | September 10, 2018 | December 30, 2023 |
| NCT00813631 | Unknown status | Phase 4 | The Effect on an Ionic Silver Dressing in Head and Neck Patients With Malignant Fungating Wound | January 2009 | November 2009 |
| NCT02283489 | Unknown status | Phase 2 | Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors | October 2014 | October 2016 |
| NCT04435938 | Unknown status | Phase 2 | A Study of SBRT for Squamous Cell Carcinoma of the Head and Neck | September 10, 2020 | December 2022 |
| NCT03356587 | Unknown status | Phase 2 | A Biomarker-driven, Open Label, Single Arm, Multicentre Phase II Study of Abemaciclib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Who Failed to Platinum-based Therapy | October 16, 2017 | December 31, 2020 |
| NCT03171558 | Unknown status | N/A | Gastric Pull up Versus Free Flap Reconstruction for Laryngo-pharyngeal Defects | March 16, 2017 | March 2023 |
| NCT03114202 | Unknown status | N/A | Effects of Nutritional Counseling on Nutritional Status and Quality of Life of Head and Neck Cancer Patients | April 18, 2017 | October 1, 2018 |
| NCT03875833 | Withdrawn | N/A | Prospective Analysis of Effect of Collagen Wrap Conduit on Radial and Ulnar Nerve Function Following Radial/Ulnar Forearm Free Flap Harvest | October 9, 2020 | January 1, 2024 |
| NCT01175499 | Withdrawn | N/A | Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract | July 2010 | |
| NCT03561324 | Withdrawn | N/A | Intraoperative Imaging of a PET Positive Lymph Node(s) Using 18FDG and a Dual-Mode, Hand-Held Intraoperative Imager | June 20, 2018 | January 22, 2020 |
| NCT01621048 | Withdrawn | Evaluation of Treatment Related Toxicity After Radiotherapy for Head and Neck Cancer | June 2012 | December 2016 | |
| NCT00038038 | Withdrawn | N/A | Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole | January 1994 | June 2003 |
| NCT01020864 | Withdrawn | Phase 2 | Cetuximab in Combination With Chemotherapy for Patients With Head and Neck Cancer | January 2010 | January 2012 |
| NCT01262859 | Withdrawn | Phase 2 | Pilot Study for Locally Advanced Head and Neck Cancer | December 2010 | July 2011 |
| NCT00363441 | Withdrawn | Phase 2/Phase 3 | A Study of Conventional 3D Radiation vs. Intensity-Modulated Radiation in Squamous Cell Cancer of the Head and Neck | ||
| NCT03906838 | Withdrawn | Early Phase 1 | Regional Anesthesia Block in Fibula Free Flap Reconstruction | January 1, 2020 | November 30, 2020 |
| NCT01747512 | Withdrawn | Phase 2 | An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT) | ||
| NCT02216669 | Withdrawn | Phase 1 | Trial to Determine Optimal Phase II Dose of the Oral Dual CAIX Inhibitor/ Radiosensitizer | March 2017 | July 2017 |
| NCT02908386 | Withdrawn | ROCOCO - Adaptive IMRT Versus IMPT in Head and Neck Cancer | November 2015 | November 2016 | |
| NCT03971760 | Withdrawn | N/A | Ideal Drainage Output of Post-operative Neck Suction Drain | November 2021 | June 2022 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D006258